LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Aigen Investment Management, LP's Holding History (CIK: 0001741224)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 18,972 Value ($000) $26 Avg Close — Range —
Q2 2024
Shares 17,908 Value ($000) $26 Avg Close — Range —
Q4 2023
Shares 15,268 Value ($000) $30 Avg Close — Range —
Q3 2023
Shares 14,051 Value ($000) $21 Avg Close — Range —